The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 07, 2020
Filed:
Jun. 15, 2018
Applicant:
Modernatx, Inc., Cambridge, MA (US);
Inventors:
Giuseppe Ciaramella, Sudbury, MA (US);
Eric Yi-Chun Huang, Boston, MA (US);
Kapil Bahl, Medford, MA (US);
Tal Zaks, Newton, MA (US);
Sunny Himansu, Winchester, MA (US);
Sayda Mahgoub Elbashir, Cambridge, MA (US);
Assignee:
ModernaTX, Inc., Cambridge, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/12 (2006.01); C07K 14/005 (2006.01); A61K 9/14 (2006.01); A61K 9/00 (2006.01); C07K 16/28 (2006.01); C07K 16/10 (2006.01); A61K 47/10 (2017.01); A61K 47/18 (2017.01); A61K 47/22 (2006.01); A61K 47/28 (2006.01); C12N 7/00 (2006.01); A61P 31/12 (2006.01); A61P 31/14 (2006.01); A61K 9/51 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/12 (2013.01); A61K 9/0019 (2013.01); A61K 9/14 (2013.01); A61K 9/51 (2013.01); A61K 47/10 (2013.01); A61K 47/183 (2013.01); A61K 47/22 (2013.01); A61K 47/28 (2013.01); A61P 31/12 (2018.01); A61P 31/14 (2018.01); C07K 14/005 (2013.01); C07K 16/1081 (2013.01); C07K 16/2851 (2013.01); C12N 7/00 (2013.01); A61K 9/5123 (2013.01); A61K 2039/505 (2013.01); A61K 2039/5252 (2013.01); A61K 2039/5254 (2013.01); A61K 2039/53 (2013.01); A61K 2039/543 (2013.01); A61K 2039/545 (2013.01); A61K 2039/6056 (2013.01); C07K 2317/33 (2013.01); C07K 2317/76 (2013.01); C12N 2770/24122 (2013.01); C12N 2770/24123 (2013.01); C12N 2770/24134 (2013.01); C12N 2770/36034 (2013.01); C12N 2770/36122 (2013.01); C12N 2770/36123 (2013.01); C12N 2770/36134 (2013.01); Y02A 50/383 (2018.01); Y02A 50/386 (2018.01); Y02A 50/39 (2018.01); Y02A 50/392 (2018.01); Y02A 50/51 (2018.01);
Abstract
Aspects of the disclosure relate to nucleic acid vaccines. The vaccines include one or more RNA polynucleotides having an open reading frame encoding one or more Chikungunya antigen(s), one or more Zika virus antigens, and one or more Dengue antigens. Methods for preparing and using such vaccines are also described.